People with late-stage Parkinson’s disease (PD) often suffer from debilitating locomotor deficits that are resistant to currently available therapies. To alleviate these deficits, we developed a neuroprosthesis operating in closed loop that targets the dorsal root entry zones innervating lumbosacral segments to reproduce the natural spatiotemporal activation of the lumbosacral spinal cord during walking.
We first developed this neuroprosthesis in a non-human primate model that replicates locomotor deficits due to PD. This neuroprosthesis not only alleviated locomotor deficits but also restored skilled walking in this model. We then implanted the neuroprosthesis in a 62-year-old male with a 30-year history of PD who presented with severe gait impairments and frequent falls that were medically refractory to currently available therapies. We found that the neuroprosthesis interacted synergistically with deep brain stimulation of the subthalamic nucleus and dopaminergic replacement therapies to alleviate asymmetry and promote longer steps, improve balance and reduce freezing of gai
Source: Healthcare Press (healthcarepress.net)
Neuroprosthesis Parkinson's Disease Locomotor Deficits Walking Ability Gait Impairments
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: AustinChronicle - 🏆 593. / 51 Read more »
Source: physorg_com - 🏆 388. / 55 Read more »
Source: SciTechDaily1 - 🏆 84. / 68 Read more »
Source: PsychToday - 🏆 714. / 51 Read more »
Source: Medscape - 🏆 386. / 55 Read more »
Source: nbcsandiego - 🏆 524. / 51 Read more »